Personalized Medicine - BIO SmartBrief

Find/Post Jobs

Partner With Us

Advertise

About SmartBrief

Reader Polls

Personalized Medicine All Sources News Press Releases Editors Pick
New law bans genetic discrimination Los Angeles Times \| 1 day 10 hours 20 minutes ago The Genetic Information Nondiscrimination Act, the most sweeping anti-discrimination law in nearly 20 years, prohibits employers from hiring or firing based on a person's genetic makeup. Gene preferences banned Spokesman-Review (Spokane, Wash.), The \| 1 day 10 hours 31 minutes ago WASHINGTON ? The first federal anti-discrimination law in nearly 20 years takes effect today, prohibiting employers from hiring, firing or determining promotions based on genetic makeup. New Law Prohibits Genetic Discrimination Sun (Baltimore), The \| 1 day 17 hours 10 minutes ago The first federal anti-discrimination law in nearly 20 years takes effect today, prohibiting employers from hiring, firing or determining promotions based on genetic makeup. Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost [Press Release] PRNewswire \| 1 day 18 hours 15 minutes ago NEW YORK, Nov. 20 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc Genetic analysis helps dissect molecular basis of cardiovascular disease EurekAlert! \| 2 days 1 hour 11 minutes ago Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy, researchers performed genetic association analysis across the whole genome among 17,296 women of European ancestry. This large scale analysis of the effects of common genetic variation on plasma lipoprotein profile, a critical component of cardiovascular risk, identified 43 genetic loci contributing to lipoprotein metabolism. The findings are published on Nov. 20 in th... BioPharma Today: PBM Power Behind Pharmacogenomics: CVS Caremark Launching Program BioPharma Today \| 2 days 2 hours 55 minutes ago CVS Caremark is expanding its commitment to pharmacogenomics with a new clinical and testing services program being developed in collaboration with newly-formed Generation Health, which describes itself as a genetic benefits management company. Announced Nov. 10, the program initially is expected to focus on predicting how patients respond to about a dozen drugs in therapeutic areas including oncology, cardiovascular disease and HIV treatment. Read on..... Moffitt Cancer Center Awarded Nearly $19 Million in Recovery Act Grants [Press Release] PRNewswire \| 2 days 18 hours 46 minutes ago ...nation awarded for patient-centered outcomes research in personalized medicine. Moffitt's work in this area is focused on providing...Moffitt's efforts to develop, discover and deliver personalized medicine for cancer patients here in Florida, and we strive to... KineMed Receives an Investigator-Initiated Study Grant to Further Explore Mechanism(s) of Action Associated with Welchol (colesevelam HCl) in Type 2 Diabetes Mellitus [Press Release] Business Wire \| 2 days 21 hours 14 minutes ago KineMed, Inc., a translational and personalized medicine development company, announced today that the company has received an investigator initiated study grant from Daiichi Sankyo, Inc. to conduct a clinical study designed to better understand and characterize the beneficial effects of Welchol® (colesevelam HCl) in patients with Type 2 Diabetes Mellitus (T2DM). SeraCare Reports Fourth Quarter and Fiscal Year 2009 Results [Press Release] Business Wire \| 2 days 21 hours 42 minutes ago SeraCare Life Sciences, Inc. (NASDAQ: SRLS), a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today reported operational and financial results for its fourth quarter and fiscal year ended September 30, 2009. Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) [Press Release] PRNewswire \| 2 days 22 hours 6 minutes ago MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. announced today the dosing of the first patient in a randomized Phase 2B study of AEG35156, a targeted antisense therapeutic in mid-stage development for multiple oncology indications. Sweet corn story begins in UW-Madison lab EurekAlert! \| 2 days 23 hours 38 minutes ago This week, scientists are revealing the genetic instructions inside corn, one of the big three cereal crops. Corn, or maize, has one of the most complex sequences of DNA ever analyzed, says University of Wisconsin-Madison genomicist David Schwartz, who was one of more than 100 authors in the article in the journal Science. Research and Markets: Monitoring Health Through Novel Technologies: Where Are We with Point-of-Care Diagnostics? [Press Release] Business Wire \| 3 days 3 hours 45 minutes ago Research and Markets (http://www.researchandmarkets.com/research/b6b2b6/monitoring_health) has announced the addition of Decision Resources, Inc.'s new report "Monitoring Health Through Novel Technologies: Where Are We with Point-of-Care Diagnostics?" to their offering. Research and Markets: Cancer Therapies - Global Market Opportunities [Press Release] Business Wire \| 3 days 5 hours 6 minutes ago Research and Markets (http://www.researchandmarkets.com/research/4b82d8/cancer_therapies) has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering. Personalized Medicine Drives Multiple Markets, Finds Frost & Sullivan Bioresearch Online \| 3 days 5 hours 23 minutes ago In the near future, the firm plans to conduct analyses of additional personalized medicine markets: Companion Diagnostics Markets Epigenetics Markets Histopathology Markets Next Generation Sequencing Markets Ignite Institute plans center for genetic research FasterCures SmartBrief \| 3 days 12 hours 45 minutes ago ...415 jobs in the next five years and would collaborate with Inova Health System, said Dietrich Stephan, the nonprofit group's founder and geneticist. Research at the $200 million facility is expected to focus on personalized medicine. 1 2 3 4 5 6 7 8 9 ... Next > 488 Results

Sign up for BIO SmartBrief

Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more

Latest Blog Postsview more

Weekly Roundup - 11-20-09
Eye on FDA

Head Lice Treatment
Science Blog

Head Lice Treatment
Science Blog

Melanoma News Database MMMP
Science Blog

Companies in the news